Ftse Mib
34.816,78
-1,64%
DAX
18.768,96
0,33%
S&P 500
5.308,13
0,09%
NASDAQ
16.794,87
0,65%
Bitcoin
69.644,99
5,09%

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Oncology Institute Inc (TOI) Oncology Institute Inc (TOI) Notizie

Oncology Institute Inc

TOI
0,6294
-0,0096 (-1,50%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 23:42:26
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
14/5/202422:05GLOBEThe Oncology Institute Reports First Quarter 2024 Financial..
07/5/202422:05GLOBEThe Oncology Institute to Participate in Panel Discussion at..
23/4/202414:00GLOBEThe Oncology Institute Announces First Quarter 2024 Earnings..
08/4/202414:00GLOBEJordan McInerney Appointed as Chief Development Officer of..
04/4/202414:00GLOBEThe Oncology Institute and Healthly Forge Strategic Alliance..
27/3/202421:05GLOBEThe Oncology Institute Reports Fourth Quarter and Full Year..
14/3/202413:09GLOBEMaxHealth & The Oncology Institute Expand Value-Based Care..
06/3/202414:00GLOBEThe Oncology Institute Announces Fourth Quarter and Full..
27/2/202422:05GLOBEThe Oncology Institute to Participate at Upcoming Investor..
20/2/202414:00GLOBECarrum Health and The Oncology Institute Partner on Breast..
25/1/202414:00GLOBEWellBe Senior Medical Partners with The Oncology Institute..
19/1/202422:00EDGAR2Form 144 - Report of proposed sale of securities
28/12/202323:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:38EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/12/202323:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/12/202301:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202314:00GLOBEThe Oncology Institute Expands its Specialty Medication..
23/11/202303:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202302:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
23/11/202302:37EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202301:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/11/202323:27EDGAR2Form 144 - Report of proposed sale of securities
16/11/202322:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202321:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/11/202300:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202323:17EDGAR2Form 144 - Report of proposed sale of securities
08/11/202322:43EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202322:41EDGAR2Form 8-K - Current report
08/11/202322:05GLOBEThe Oncology Institute Reports Third Quarter 2023 Financial..
18/10/202314:03GLOBEThe Oncology Institute Announces Third Quarter 2023 Earnings..
11/10/202322:05GLOBEThe Oncology Institute Names Jeremy Castle as Chief..
26/9/202322:05GLOBEThe Oncology Institute Executive Leaders to Present at the..
18/9/202314:00EDGAR2Form 8-K - Current report
18/9/202314:00GLOBEThe Oncology Institute Regains Compliance with Nasdaq..
07/9/202320:36EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/9/202322:07EDGAR2Form 8-K - Current report
01/9/202322:00EDGAR2Form 8-K - Current report
30/8/202321:04EDGAR2Form 8-K - Current report
10/8/202323:15EDGAR2Form 8-K - Current report
09/8/202322:27EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/8/202314:10GLOBEAmbience Healthcare and The Oncology Institute (TOI) Partner..
08/8/202322:40GLOBEThe Oncology Institute Reports Second Quarter 2023 Financial..
31/7/202314:00GLOBEThe Oncology Institute Partners with House Rx to Accelerate..
18/7/202314:00GLOBEThe Oncology Institute Announces Second Quarter 2023..
12/6/202312:00GLOBEThe Oncology Institute Announces Leadership Transition
09/6/202314:00GLOBEThe Oncology Institute (TOI) and Massive Bio Forge..
07/6/202314:00GLOBEThe Oncology Institute to Open Project Southland
31/5/202314:01GLOBEThe Oncology Institute Featured on Four Abstracts at ASCO..
31/5/202314:00GLOBEThe Oncology Institute to Participate at Upcoming Investor..
Apertura: 0,62 Min: 0,60 Max: 0,639
Chiusura: 0,639

La tua Cronologia

NASDAQ
TOI
Oncology Institute
TSX
NHYB
NBI High Yield Bond ETF
LSE
0HDQ
Synergie
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' CLICCA QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network